These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33438085)

  • 41. The association of uremic toxins and inflammation in hemodialysis patients.
    Hsu HJ; Yen CH; Wu IW; Hsu KH; Chen CK; Sun CY; Chou CC; Chen CY; Tsai CJ; Wu MS; Lee CC
    PLoS One; 2014; 9(7):e102691. PubMed ID: 25051062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.
    Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
    Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis?
    Reis DCMV; Alvarenga L; Cardozo LFMF; Baptista BG; Fanton S; Paiva BR; Ribeiro-Alves M; Fortunato RS; Vasconcelos AL; Nakao LS; Sanz CL; Berretta AA; Leite M; Mafra D
    Clin Nutr ESPEN; 2024 Feb; 59():96-106. PubMed ID: 38220413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial.
    Esgalhado M; Kemp JA; Paiva BR; Brito JS; Cardozo LFMF; Azevedo R; Cunha DB; Nakao LS; Mafra D
    Food Funct; 2020 Mar; 11(3):2617-2625. PubMed ID: 32159187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
    Sirich TL; Plummer NS; Gardner CD; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1603-10. PubMed ID: 25147155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study.
    Alvarenga L; Salarolli R; Cardozo LFMF; Santos RS; de Brito JS; Kemp JA; Reis D; de Paiva BR; Stenvinkel P; Lindholm B; Fouque D; Mafra D
    Clin Nutr; 2020 Dec; 39(12):3594-3600. PubMed ID: 32204978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating
    Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Unripe Banana Flour on Gut-Derived Uremic Toxins in Individuals Undergoing Peritoneal Dialysis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    de Andrade LS; Sardá FAH; Pereira NBF; Teixeira RR; Rodrigues SD; de Lima JD; Dalboni MA; Aoike DT; Nakao LS; Cuppari L
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.
    Vanholder R; Schepers E; Pletinck A; Nagler EV; Glorieux G
    J Am Soc Nephrol; 2014 Sep; 25(9):1897-907. PubMed ID: 24812165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
    Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
    Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can oral therapy reduce uremic toxins?
    Depner TA; Cowgill LD
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1513-5. PubMed ID: 25147156
    [No Abstract]   [Full Text] [Related]  

  • 54. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial.
    Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D
    J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
    Boelaert J; Lynen F; Glorieux G; Eloot S; Van Landschoot M; Waterloos MA; Sandra P; Vanholder R
    Anal Bioanal Chem; 2013 Feb; 405(6):1937-47. PubMed ID: 23307120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial.
    Takkavatakarn K; Puapatanakul P; Phannajit J; Sukkumme W; Chariyavilaskul P; Sitticharoenchai P; Leelahavanichkul A; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of bowel habits on gut-derived toxins in peritoneal dialysis patients.
    Pereira NBF; Ramos CI; de Andrade LS; Teixeira RR; Nakao LS; Rodrigues SD; de Lima JD; Dalboni MA; Cuppari L
    J Nephrol; 2020 Oct; 33(5):1049-1057. PubMed ID: 32737690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.
    Kalim S; Wald R; Yan AT; Goldstein MB; Kiaii M; Xu D; Berg AH; Clish C; Thadhani R; Rhee EP; Perl J
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):436-444. PubMed ID: 29444900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.